Document Detail


Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
MedLine Citation:
PMID:  15929758     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Aberrant crypt foci may represent preneoplastic lesions in the human colon. The prevalence of aberrant crypt foci detected using magnification chromoscopic colonoscopy is known to follow a stepwise progression from normal subjects to those with exophytic adenomas and colon cancer. No studies have addressed the prevalence of rectal aberrant crypt foci in patients with flat and depressed colonic lesions that cluster within the right hemi-colon and may undergo de novo neoplastic transformation. METHODS: All patients underwent total colonoscopy by a single endoscopist using the Olympus CF240Z magnifying colonoscope. Flat and depressed lesions were diagnosed using targeted indigo carmine chromoscopy. Prior to extubation, pan high-magnification-chromoscopy using indigo carmine was applied to the rectum and the distal 10 cm of mucosa examined using forward and retroflexed views. Aberrant crypt foci were defined as two or more crypts with dilated or slit-like openings that were raised above the adjacent mucosa. Using high-magnification chromoscopic colonoscopy we assessed the prevalence and dysplastic features of aberrant crypt foci in three groups: endoscopically "normal" subjects, patients with flat/depressed adenoma, and flat/depressed cancer. RESULTS: Two thousand five hundred and fifty-nine patients underwent colonoscopy of which 1,000 were eligible for inclusion. The median number of aberrant crypt foci per patient in the endoscopically normal, adenoma, and cancer group was 1 (range: 0-5), 9 (range: 0-22), and 38 (range: 14-64), respectively. The estimated relative risk of dysplastic aberrant crypt foci when comparing the flat adenoma group with the endoscopically "normal" group was 4.68 (95% CI: 2.23-9.91) with the relative risk for flat cancer versus endoscopically normal group being 21.8 (95% CI: 10.9-23.8). Patients with >5 flat adenomas had higher crypt foci densities than those with <5 adenomas (r=0.53; p<0.001). CONCLUSIONS: The number of aberrant crypt foci in normal patients, patients with flat adenoma, and flat cancer follow a stepwise incremental change as previously observed for exophytic adenomas and cancer. Detection of aberrant crypt foci in the rectum may be a useful biomarker for proximal colonic flat neoplasia and could be used at index flexible sigmoidoscopic screening to stratify risk of proximal colonic neoplasia. Patients with dysplastic aberrant crypt foci of high density should receive total colonoscopy.
Authors:
David P Hurlstone; Mohammed Karajeh; David S Sanders; Sister K Drew; Simon S Cross
Related Documents :
19621338 - The cancer stem cell marker cd133 has high prognostic impact but unknown functional rel...
21058188 - Avenanthramides inhibit proliferation of human colon cancer cell lines in vitro.
20345478 - Insulin resistance and cancer: epidemiological evidence.
1192408 - Fecal bacteriology of colonic polyp patients and control patients.
23666588 - The number of nodes removed as well as the template of the dissection is independently ...
20162578 - Tubulin tyrosine ligase like 12 links to prostate cancer through tubulin posttranslatio...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  The American journal of gastroenterology     Volume:  100     ISSN:  0002-9270     ISO Abbreviation:  Am. J. Gastroenterol.     Publication Date:  2005 Jun 
Date Detail:
Created Date:  2005-06-02     Completed Date:  2005-08-09     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0421030     Medline TA:  Am J Gastroenterol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1283-9     Citation Subset:  IM    
Affiliation:
Gastroenterology and Liver Unit at the Royal Hallamshire Hospital; and Academic Unit of Pathology, Section of Oncology and Pathology, Division of Genomic Medicine, University of Sheffield Medical School, Sheffield, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenoma / epidemiology,  pathology*
Adolescent
Adult
Aged
Aged, 80 and over
Colon / pathology
Colonoscopy / methods*
Colorectal Neoplasms / classification,  epidemiology,  pathology*
Coloring Agents / diagnostic use*
Disease Progression
Female
Humans
Indigotindisulfonate Sodium / diagnostic use*
Intestinal Mucosa / pathology*
Male
Middle Aged
Precancerous Conditions / pathology*
Prevalence
Prospective Studies
Rectum / pathology
Risk Factors
Sensitivity and Specificity
Chemical
Reg. No./Substance:
0/Coloring Agents; 860-22-0/Indigotindisulfonate Sodium
Comments/Corrections
Comment In:
Nat Clin Pract Gastroenterol Hepatol. 2005 Sep;2(9):390-1   [PMID:  16265426 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Host TNF-alpha-1031 and -863 promoter single nucleotide polymorphisms determine the risk of benign u...
Next Document:  Impact of bending section length on insertion and retroflexion properties of pediatric and adult col...